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ABSTRACT
ypertension if untreated or uncontrolled, 
leads to damage of vital organs such as the 
1Hbrain, heart and kidneys among others.  With 
about one billion people affected, hypertension (HTN) 
is the most prevalent Cardio-Vascular Disease (CVD) 
that contributes to cardiovascular morbidity and 
2mortality world-wide.  Complications of HTN have 
3been shown to be severer in black Africans.  Benefit of 
treatment has been repeatedly demonstrated by many 
4,5 studies. However, treatment of HTN in several 
regions of the world remains suboptimal due to various 
barriers pertaining to the patient, to the health care 
professionals or to the health system. Many guidelines 
have been produced by relevant bodies in different 
countries in order to assist physicians in making the 
right choices for blood pressure (BP) control.
INTRODUCTION
BACKGROUND 
Hypertension, if untreated or uncontrolled, leads to damage of vital organs such as the brain, heart and the kidneys 
among others. These complications have been shown to be severer in black Africans. Benefit of treatment has been 
 repeatedly demonstrated by many studies. Therefore, many guidelines have been produced by relevant bodies in 
different countries in order to assist physicians in making the right choices for blood pressure (BP) control. Most of 
these bodies produce the guidelines based on the peculiarities of hypertension in their respective population. 
 Several reports have shown how different hypertension is, in black Africans, still there is no published unified 
guideline for its treatment in this population. 
METHODS
This was a survey of known hypertensives who were on follow up visit. Their prescriptions were assessed for drug 
name, class and number. Their blood pressures at that visit were also recorded. Prevalence of single therapy and 
combination therapy were determined. Compliance with the AHA recommended 2 – drug combination was 
determined. The percentage of BP control as well as the prescribed drugs in each group were also obtained. 
RESULTS
Those on single agents were 13% out of which 52% were controlled. 87% were on various combination of 2 or 
more drugs of whom 41.9% of those on 2 drugs and 21.1% of those on more than 2 drugs had controlled BP. BP 
control in those on 2 drugs was better than in those with > 2 drugs, (p=0.0027).
ACEI were the commonest used drug either as single agent (55.9%) or as 2 – drug combination as seen in 54.8% of 
the subjects on 2 – drug combination. 13 different 2 – drug combinations were identified with the best control in 
ARB + Diuretic, ACEI + Diuretic and CCB + Diuretic. The least control was observed in the ACEI + CCB group. 
Compliance with AHA recommendation was good but still 7.7% were under unacceptable group while another 
7.7% were unclassified. 
CONCLUSION
ACE-Is are becoming the drugs of choice both as monotherapy and as combination therapy.  Despite good 
compliance to AHA recommendation on drug combination, overall control is still a problem which calls for a 
revisit of these recommendations in Africans.
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the prescribed drugs as single agents in this study 
population.
The vast majority of the subjects, 288 (87.0%), were on 
various combination of 2 or more drugs, out of which 
155 were on 2 drugs, 112 were on 3 drugs and 21 on 
various 4 drug combinations. A total of 13 different two 
drug combinations were observed. As with the drug of 
choice in those on single drugs, ACEIs were the most 
frequently used agent in two drug combination. It was 
observed to be used in 85 of the 155 subjects (54.8%).  
Table 1 shows the frequency of the various 
combination therapies.
Of the various 2 drug combinations that were observed 
in this study, 53.6% fell under the “preferred” 2-drug 
recommendation of the American Society of 
Hypertension (ASH) recommendation, 31% fell under 
“acceptable” recommendation, 7.7% were under “less 
effective” group while another 7.7% were 
combinations that were not classified in the ASH 
recommendations. 
Most of these bodies produce the guidelines based on 
the peculiarities of hypertension in their respective 
population. Several reports have shown how different 
6,7hypertension is, in black Africans , but still there is no 
published guideline for effective treatment of 
hypertension in this population. This study therefore 
seeks to find the pattern of prescription for 
hypertension and its impact on BP control in Nigerians 
with hypertension.    
METHODS
This was a cross sectional study in which consecutive 
patients who attended the cardiac clinic of Aminu 
Kano Teaching Hospital, for follow up visit were 
recruited for the survey. Information on their personal 
data like age, sex and duration of hypertension were 
obtained. Their prescriptions were assessed to check 
the number of drugs, name of the drug(s), and class of 
the drug(s). Their blood pressures at that visit were also 
obtained and recorded. Prevalence of single therapy 
and combination therapy were determined. The 
percentage of BP control in each group was also 
d e t e r m i n e d .  T h e  c o m m o n e s t  p r e s c r i b e d  
antihypertensive as well as the commonest 2 – drug 
combination were found. BP control in these groups 
was also assessed. Compliance with the American 
Society of Hypertension (ASH) recommended 2 – drug 
8combination  was also determined.
The statistical analysis was carried out using Statistical 
Package of Social sciences (SPSS) version 16.0 software. 
Frequencies, ranges, and means with standard 
deviations were used to describe patients' 
characteristics where appropriate. Chi-squared, 
Fisher's exact, and Student's t tests were used to 
compare categorical and continuous variables as 
appropriate. A statistical significance was set at the 
conventional p< 0.05. 
RESULTS
A total of 331 subjects completed the study comprising 
of 128 males and 203 females (sex ratio 1:1.6). The mean 
duration of hypertension in the study subjects was 8.49 
±7.17 years. Their ages ranged from 18-85 (with mean of 
55.97±11) years. 
Those on single agents were only 43 (13.0%) out of the 
total subject number of 331. In this group, various 
Angiotensin Converting Enzyme Inhibitors (ACEIs) 
were the commonest prescribed anti-hypertensives as 
it was used in 24 of the 43 subjects (55.9%). This was 
followed by diuretics that was used in 16.3%, Calcium 
Channel Blockers (CCB) in 9.3%, Beta Blocker (β. 
Blocker) in 7.0%, centrally acting agent 7% and lastly 
Angiotensin Receptor Blocker (ARB) that was 
prescribed for 4.7%. Central alpha-2 receptor agonists, 
renin inhibitors and direct vasodilators are not among 
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Table 1: The Various Combination Therapies in the 
study population
Abbreviations: ARB = Angiotensinsin receptor 
blocker; ACEI = Angiotensin Enzyme Inhibitor; CCB = 
Calcium Channel Blockers; β = beta as illustrated in 
table 2, the subjects that were on single drugs had 
better BP control while the participants on 2 drugs 
have a statistically significant higher chance of BP 
control than those on more than 2 drugs, (p=0.0027). 
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Table 2: Frequencies, and control status by number of drugs.
In those on 2 drug combination, the best control was seen in ARB & Diuretic group (Table 3), in which 3 of the 6 
patients on this combination had their BPs under control (50%), this was followed by the ACEIs & Diuretic group in 
which control was seen in 24 of 52 (46.2%). In those on CCB & Diuretics, control was seen in 18 of the 42 (42.9%) 
subjects. A much lesser control rate of 9.1% was observed in the CCB combined with ACE-Is group. 
Table 3: Types of 2 – drug combination therapies by BP control
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find, from this study, that only a few patients (7.7%) 
were on the less effective 2 drug combinations based on 
17ASH guidelines  and another 7.7% were on 
combinations that were not recognized by the ASH. 
This clearly indicates familiarity, acceptability and 
high level of adherence to the guidelines on 
combination of antihypertensives. 
Our study has shown that patients on two drug 
combinations achieved higher BP control (41.9%) than 
patients on 3 or more drugs (21.1%), but the best control 
was observed in those on single agents (52%). This is 
probably due to the fact that patients on more than 2 
drugs are the ones with high CVD risk with very 
difficult to treat BP, additionally, polypharmacy 
discourages patient compliance. This, therefore, points 
towards encouragement of developing fixed 
combination drugs which will potentially enhance 
patient compliance and perhaps better BP control. 
Putting all the patients of this study together, the 
proportion of those with controlled BP was 34.7%. This 
9,20 is not different from other reports from Nigeria and 
21other parts of the world  in which control rates were 
also low. 
Among the patients on 2 drug combinations, the best 
control was seen in those on either ACE-Is or ARBs 
combined with diuretics, where control was achieved 
in 47.5%. This relatively high control rate when 
9,20compared with reported control rates,  could be due 
to the fully additive BP reduction of the 2 classes of 
22,23drugs used.  Diuretics cause intravascular volume 
depletion following which renin-angiotensin-
aldosterone system (RAAS) becomes activated which 
then produces vasoconstriction. Addition of either 
ACE-Is or ARB therefore abolishes this counter-
regulatory mechanism. A near similar control rate 
(42.9%) was observed in those on combination of CCB 
with diuretic. Though the control rate is not good 
enough, it is also higher than the overall control rate of 
34.7% observed in the patients of this study and higher 
than that of other reports. The control rate in this group 
can partly be due to the overlap in the pharmacological 
properties of the 2 classes of drug which produces a 
24,25 partial additive BP reduction. Diuretics cause 
increased renal sodium excretion so also CCB but to a 
lesser extent. It is also known that prolonged use of 
both classes of drugs lead to vasodilatation.  The 
relatively low control rate that was seen in the CCB 
with ACE-Is group is quite surprising because this 
combination is supposed to also produce a fully 
26,27 additive BP reduction. This unexpected finding may 
be due to the small number of the patients in this group 
(22). Additionally compliance to the drugs cannot be 
ascertained just like in all other groups with the various 
combination therapy. 
DISCUSSION
There were 43 (13.1%) patients on single 
antihypertensive agent, while the majority, 86.9% were 
on combination of 2 or more anti-hypertensives. This 
seemingly high proportion of combination therapy is 
consistent the findings in other parts of Nigeria where 
9 the proportions were 80% in Sokoto,  and 73% in 
10 Ibadan. This high proportion of patients on 
combination therapy suggests that most of our 
hypertensives have either moderate or severe 
hypertension, just in keeping with the knowledge that 
hypertension is severer in blacks. It may also be the 
result of compliance to current trends where 
11combination therapy is advocated.  
Furthermore, more recent findings suggest that BP 
response to ACE-Is does not vary with patient's race 
but with individual factors such as age, body mass 
index, baseline BP readings and presence of  Diabetes 
14,15Mellitus.  Generally speaking, the choice of ACE-Is in 
our environment is  commendable because 
hypertensives usually present late when cardiac and 
renal complications would have set in.
β-Blockers were the least prescribed as 
observed in this study because studies from other parts 
12,13of Nigeria  made the same observations.    
ACE-Is was also the most used agent in two drug 
combinations which was used in 85 of the 155 subjects 
on two drug combination (54.8%).  Lisinopril was the 
ACE-I used in nearly all cases of single and 
combination therapies, because it is cheap and readily 
available. Combinations of ACE-Is and diuretics was 
the most prescribed combination. The choice of 
diuretics as an add-on can be due to the belief that 
hypertension in blacks responds more to this class of 
drugs than it does for other agents. Furthermore, it is 
believed that combination of ACE-Is with thiazide 
diuretics in black hypertensives results in improved BP 
16control and target organ protection.    The above 
combination is among the preferred combinations 
recommended by the American Society of 
17Hypertension (ASH),  1996 Nigerian Society of 
18Hypertension guideline  and 2014 South African 
19Hypertension guidelines.  It is quite commendable to 
Angiotensin 
Converting Enzyme-Inhibitors were the most 
commonly used antihypertensives as a single agent as 
it was prescribed to 55.8% of those on single drug. This 
was followed by diuretics that was prescribed to 16.3%, 
then CCB had 7.0%, centrally acting agents had 7.0% 
and ARB 4.6%. This observation is different from those 
of earlier Nigerian reports in which diuretics were the 
9,10 most commonly prescribed single agents. It is also 
different from other studies where CCB were found to 
12,13 be the most frequently prescribed single agents. This 
shift of choice of single agent may be due to current 
knowledge of the advantages of ACE-Is in treating 
hypertensives with chronic kidney disease. 
 It is not 
surprising that 
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CONCLUSION
The results suggest that ACE-Is are the most prescribed 
agents both as monotherapy and as combination 
treatment. While BP control was better in those on 
single agent, it was observed to be more among those 
on either ACE-Is or ARB with diuretic in the patients on 
2-drug combination. However, the control rates are still 
low despite compliance to AHA recommendation on 
drug combination. Overall, control is still a problem 
which calls for a revisit of these recommendations in 
Africans.
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